Jinming Yu

1.6k total citations · 1 hit paper
38 papers, 1.1k citations indexed

About

Jinming Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jinming Yu has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Jinming Yu's work include Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Jinming Yu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Jinming Yu collaborates with scholars based in China, United States and United Kingdom. Jinming Yu's co-authors include Li Kong, Feifei Teng, Xin Wang, Song Xue, Ge Song, Yongjun Lu, Ming Yang, Hui Zhu, Mengyu Xie and Bing Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Scientific Reports.

In The Last Decade

Jinming Yu

36 papers receiving 1.1k citations

Hit Papers

PD-L1 expression in human cancers and its association wit... 2016 2026 2019 2022 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PD-L1 expression in human cancers and its association with clinical outcomes
    2016 608 citations Jinming Yu, Xin Wang et al. OncoTargets and Therapy profile →

Peers

Jinming Yu
Simon Laban Germany
Hari Menon United States
Julie E. Stein United States
An Coosemans Belgium
Shuji Kitahara Japan
Ritesh Rathore United States
Ricardo Zwirtes United States
Toby Mellows United Kingdom
Michele Iuliani Italy
Runbo Zhong China
Simon Laban Germany
Jinming Yu
Citations per year, relative to Jinming Yu Jinming Yu (= 1×) peers Simon Laban

Countries citing papers authored by Jinming Yu

Since Specialization
Citations

This map shows the geographic impact of Jinming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Yu more than expected).

Fields of papers citing papers by Jinming Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Yu. The network helps show where Jinming Yu may publish in the future.

Co-authorship network of co-authors of Jinming Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinming Yu. A scholar is included among the top collaborators of Jinming Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinming Yu. Jinming Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tourneau, Christophe Le, Zoltán Takácsi‐Nagy, Sandra Nuyts, et al.. (2025). Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC. Future Oncology. 21(12). 1489–1499. 3 indexed citations
3.
Jin, Xiu, et al.. (2024). Extreme risk spillovers in international energy markets: New insights from multilayer networks in the frequency domain. Energy Economics. 139. 107908–107908. 2 indexed citations
4.
5.
Wang, Yao, et al.. (2024). Prognostic effect of TCF1+ CD8+ T cell and TOX+ CD8+ T cell infiltration in lung adenocarcinoma. Cancer Science. 115(7). 2184–2195. 3 indexed citations
6.
Liu, Chao, Xiaohui Li, Qingyu Huang, et al.. (2023). Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. Signal Transduction and Targeted Therapy. 8(1). 44–44. 66 indexed citations
7.
8.
Wu, Fei, Zengfu Zhang, Vivek Verma, et al.. (2023). Cellular Atlas of Senescent Lineages in Radiation- or Immunotherapy-Induced Lung Injury by Single-Cell RNA-Sequencing Analysis. International Journal of Radiation Oncology*Biology*Physics. 116(5). 1175–1189. 18 indexed citations
9.
Shen, Yue, Mengyu Xie, Bowen Wang, et al.. (2022). LncRNAs LCETRL3 and LCETRL4 at chromosome 4q12 diminish EGFR-TKIs efficiency in NSCLC through stabilizing TDP43 and EIF2S1. Signal Transduction and Targeted Therapy. 7(1). 30–30. 29 indexed citations
10.
Zhu, Hui, et al.. (2022). Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical Trial. JTO Clinical and Research Reports. 3(6). 100339–100339. 3 indexed citations
11.
Zhang, Jianbo, et al.. (2021). Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma. Frontiers in Oncology. 11. 698465–698465. 9 indexed citations
12.
Ji, Shengjun, Gang Wu, Rui Lou, et al.. (2020). Screening of potential genes and transcription factors involved in post-radiation cognitive dysfunction in mice via bioinformatics. Translational Cancer Research. 9(10). 6383–6391. 1 indexed citations
13.
Yu, Jinming, et al.. (2016). Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer. OncoTargets and Therapy. 9. 823–823. 4 indexed citations
14.
Yu, Jinming, et al.. (2016). Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation. OncoTargets and Therapy. Volume 9. 4187–4196. 17 indexed citations
15.
Yu, Jinming, Xin Wang, Feifei Teng, & Li Kong. (2016). PD-L1 expression in human cancers and its association with clinical outcomes. OncoTargets and Therapy. Volume 9. 5023–5039. 608 indexed citations breakdown →
16.
Meng, Xiangjiao, Renben Wang, Zhaoqin Huang, et al.. (2014). Human epidermal growth factor receptor‐2 expression in locally advanced rectal cancer: Association with response to neoadjuvant therapy and prognosis. Cancer Science. 105(7). 818–824. 18 indexed citations
17.
Yu, Jinming, et al.. (2013). Continuous treatment with new agents for newly diagnosed multiple myeloma. Anti-Cancer Drugs. 24(5). 527–533. 10 indexed citations
18.
Yan, Hongjiang, Renben Wang, Jinming Yu, et al.. (2010). Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy. Oncology Letters. 1(4). 641–647. 12 indexed citations
19.
Lu, Yongjun, et al.. (1992). Dielectric properties of human glioma and surrounding tissue. International Journal of Hyperthermia. 8(6). 755–760. 47 indexed citations
20.
Yu, Jinming. (1991). TRANSFORMATION OF Lotus corniculatus L.MEDIATED BY Agrobacterium tumefaciens. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Laban Breakdown of academic impact, for papers by Hari Menon Breakdown of academic impact, for papers by Julie E. Stein Breakdown of academic impact, for papers by An Coosemans Breakdown of academic impact, for papers by Shuji Kitahara Breakdown of academic impact, for papers by Ritesh Rathore Breakdown of academic impact, for papers by Ricardo Zwirtes Breakdown of academic impact, for papers by Toby Mellows Breakdown of academic impact, for papers by Michele Iuliani Breakdown of academic impact, for papers by Runbo Zhong
Rankless by CCL
2026